Back to search

Poland· PL-100056552

Puder płynny wysuszający

A other antipruritics product containing zinci oxidum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 6 of our 19 countries.

ATC D04AX

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPuder płynny wysuszającyATCD04AXREGISTER NO.PL-100056552PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Zinci oxidum is registered in 6 of 19 countries.

Countries holding a registration under ATC D04AX (other antipruritics), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Zinci oxidum · ATC D04AX

6 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Zinci oxidum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
D04AX
ATC class
Other antipruritics
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990674916
  • gtin
    05909990674923
  • gtin
    05909990674930
  • gtin
    05909990682379

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Zinci oxidum in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zinci oxidum products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Labisan, Zink Aguettant
  • Belgium · Unguentum, Zinc Aguettant
  • Germany · Biolectra, Cefazink
  • Denmark · Zipzoc
  • Spain · Pasta Lassar Imba
  • Finland · Zipzoc
  • France · Effizinc, Oligosol
  • United Kingdom (Northern Ireland) · Solvazinc, Zinc & Castor Oil L.C.M
  • Greece · Zincalto, Zinctin
  • Ireland · Caldease, Zinc Ovelle
  • Iceland · Wilzin
  • Italy · Zinco Ossido Marco Viti, Zinco Ossido Nova Argentia
  • Liechtenstein · Wilzin
  • Luxembourg · Cefazink, Oligosol
  • Latvia · Cinka Rff
  • Netherlands · Daro Zinkzalf, Zinkolie
  • Norway · Wilzin
  • Portugal · Halibut, Lassadermil
  • Sweden · Zipzoc
  • Slovakia · Tekutý Púder

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/05d69c8e-50ce-4a29-93ec-e87168df43fa
GET /v1/drugs/05d69c8e-50ce-4a29-93ec-e87168df43fa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zawiesina na skórę",
  "source": "urpl",
  "strength": "250 mg/g",
  "packaging": "05909990674916 ¦ OTC ¦ Skasowane ¦ 8459\n1 op. 30 g\n05909990674923 ¦ OTC ¦ Skasowane ¦ 8460\n1 butelka 100 g\n05909990674930 ¦ OTC ¦ Skasowane ¦ 8461\n1 op. 1000 g\n05909990682379 ¦ OTC ¦ 23265\n1 tuba 100 g",
  "substance": "Zinci oxidum 25 g",
  "common_name": "Zinci oxidum",
  "pl_product_id": "100056552",
  "pozwolenie_nr": "06749",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about zinci oxidum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.